Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 6/20 | 0.58 |
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.54 |
| ▸ | SELL | P14151 | 1/20 | 0.51 |
| ▸ | SELP | P16109 | 1/20 | 0.51 |
| ▸ | CD22 | P20273 | 12/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16864028 | 0.91 | MAG (0.55) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL25761931 | 0.87 | MAG (0.47) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL13415594 | 0.87 | MAG (0.59) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL25787350 | 0.87 | MAG (0.59) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL27354542 | 0.86 | SIGLEC7 (0.53) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL16802876 | 0.85 | MAG (0.72) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL25658072 | 0.85 | SIGLEC7 (0.57) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29437858 | 0.85 | SIGLEC7 (0.57) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29437857 | 0.85 | SIGLEC7 (0.57) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL31309218 | 0.85 | SIGLEC7 (0.57) | MAGSIGLEC7SELLSELPCD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220193099-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | TARGET CAPITAL 4 LLC | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193099-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | FUT6, CSGALNACT1, FUT5 | MAG 24/4885SIGLEC7 19/4885SELL 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.